N
MYOV

Nuveen’s Myovant Sciences Ltd. MYOV Stock Holding History

Nuveen’s Portfolio MYOV Stock Details MYOV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-48,119
Closed -$598K – 3298
2022
Q2 		$598K Buy
+48,119
New +$531K ﹤0.01% 2970
2021
Q3 		– Sell
-65,856
Closed -$1.5M – 3460
2021
Q2 		$1.5M Buy
+65,856
New +$1.39M ﹤0.01% 2835

Other funds holding MYOV

Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Nuveen's MYOV Position: Q3 2022 in Review

Nuveen sold out of Myovant Sciences Ltd. (MYOV) in Q3 2022, closing a stake of 48,119 shares — an estimated $598K sold.

Nuveen first reported a position in MYOV in Q2 2021 and held it in 2 quarters. The position peaked at $1.5M in Q2 2021. 98 funds tracked by Wall St. Rank hold MYOV as of Q3 2022.

  • Nuveen reported no remaining Myovant Sciences Ltd. position as of Q3 2022 after selling out during the quarter.
  • Nuveen sold 48,119 Myovant Sciences Ltd. shares in Q3 2022, an estimated $598K.
  • Nuveen first reported a position in Myovant Sciences Ltd. in Q2 2021 and held it in 2 quarters.
  • Nuveen's Myovant Sciences Ltd. position peaked at $1.5M in Q2 2021.
  • 98 funds tracked by Wall St. Rank held Myovant Sciences Ltd. as of Q3 2022.

Based on Nuveen's 13F filing for Q3 2022, filed 14 Nov 2022.